Genotoxic effects of irinotecan combined with the novel platinum(II) complexes in human cancer cells

This publication has 64 references indexed in Scilit:

• Assessment of Cyto/Genotoxicity of Irinotecan in V79 Cells Using the Comet, Micronucleus, and Chromosome Aberration Assay
  Archives of Industrial Hygiene and Toxicology, 2010
• Topoisomerase levels determine chemotherapy response in vitro and in vivo
  Proceedings of the National Academy of Sciences, 2008
• Solution behaviour and biological activity of bisamidine complexes of platinum(II)
  JBIC Journal of Biological Inorganic Chemistry, 2007
• Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib
  European Journal of Cancer, 2007
• Cellular processing of platinum anticancer drugs
  Nature Reviews Drug Discovery, 2005
• Platinated DNA Adducts Enhance Poisoning of DNA Topoisomerase I by Camptothecin
  Journal of Biological Chemistry, 2004
• DNA double strand breaks (DSB) and non-homologous end joining (NHEJ) pathways in human leukemia
  Cancer Letters, 2003
• Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study
  European Journal of Cancer, 2002
• Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations
  Journal of Clinical Oncology, 2002
• A simple technique for quantitation of low levels of DNA damage in individual cells
  Experimental Cell Research, 1988